ArticleMikrochimica acta2025
Multimode spectral-like electrochemical fingerprinting of cysteine via biomimetic electrocatalytic interface.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
A breakthrough multimode spectral-like electrochemical profiling platform for cysteine (Cys) detection and discrimination, enabled by a rationally designed enzyme-mimetic interface that mimics the reversible Cys/cystine conversion cycle is presented. The sensing architecture was constructed through synergistic integration of vitamin B12 comodification with electrochemical activation involving sequential oxidation and reduction treatments on a glassy carbon electrode (GCE). Detailed characterization techniques, including electrochemical impedance spectroscopy (EIS), X-ray photoelectron spectroscopy (XPS), and Raman spectroscopy, systematically elucidated the formation mechanism of the bioinspired catalytic interface. The engineered interface achieves ultralow potential oxidation of Cys with simultaneous reversible reduction of oxidation products. In addition to low potential (0 V) and highly sensitive current-time (i-t) amperometric detection (with a linear range of 1 µM-1.8 mM and a detection limit of 0.1 µM), this unique interface enables multimode spectral-like discrimination via negative differential pulse voltammetric (DPV) fingerprinting (with a linear range of 1 μM-10 mM and a detection limit of 0.5 μM), effectively resolving Cys from structurally similar thiols. The superhydrophilic surface morphology endows the sensor with exceptional antibiofouling properties. This work not only establishes a novel paradigm for electrochemical thiol determination but also provides fundamental insights into biomimetic interface engineering, with direct applicability to clinical diagnostics and point-of-care monitoring.
Indexed as
Identifiers
40464785What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.